156 results
Showing 1–20 · 0.21 seconds · RSS
Oncologie
Scopus
ISSN 1765-2839 · De Gruyter · 156 articles in the index
-
Journal Article
CAP1 signaling regulates tumor immunity, proliferation, and migration in esophageal cancer
Esophageal cancer (ESCA) is a common malignancy with high morbidity and mortality. Our study aimed to explore the regulatory pathways of CAP1 in ESCA and its effects on tumor immunity.
-
Journal Article
Metabolic reprogramming and its implications for drug resistance in colorectal cancer
Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cause of cancer-related deaths. Systemic therapy encounters substantial obstacles due to treatment resistance and reduced pharmacological effectiveness, yet it remains essential for intermediate and advanced…
-
Journal Article
Emerging biomarkers for nasopharyngeal carcinoma early diagnosis and prognosis
Nasopharyngeal carcinoma (NPC) is a common malignant head and neck tumor originating in the nasopharynx. Its incidence exhibits distinct geographical heterogeneity. Although global incidence rates have declined in recent years, the disease remains highly prevalent in East and Southeast Asia…
-
Journal Article
UBE2C as a prognostic biomarker and immune modulator in breast cancer: mechanistic insights and therapeutic potential
Despite clinical advancements, challenges persist in breast cancer (BRCA) management, particularly regarding the ubiquitin-proteasome system. This study aims to comprehensively investigate the diagnostic, prognostic, and therapeutic roles of UBE2C.
-
Journal Article
Graph-based method reveals key genes and their distinct roles across acute myeloid leukemia subtypes
Acute myeloid leukemia (AML) is a heterogenous hematologic malignancy affecting both children and adults, characterized by diverse molecular alterations and variable clinical outcomes. Identifying subtype-specific gene markers is therefore important for improving disease characterization and…
-
Journal Article
PD-1 inhibition alone or combined with CTLA-4 blockade in MSI-H/dMMR metastatic colorectal cancer: refining treatment intensity
Immune checkpoint inhibition has revolutionized the management of microsatellite instability–high (MSI-H)/mismatch repair–deficient (dMMR) metastatic colorectal cancer (mCRC), a biologically distinct subgroup characterized by high tumor mutational burden, neoantigen richness, and marked immune…
-
Journal Article
A modified nutritional inflammation score to predict prognosis in patients with unresectable esophageal squamous cell carcinoma receiving first-line immunotherapy
While biomarkers related to nutrition and inflammation have been widely recognized as reliable prognostic indicators for esophageal squamous cell carcinoma (ESCC), their combined predictive efficacy in unresectable ESCC patients undergoing first-line immunotherapy has not been fully verified…
-
Journal Article
Tumor-associated macrophages-derived exosomes: research advances in breast and gynecological cancers
Exosomes secreted by tumor-associated macrophages (TAMs) function as pivotal mediators of intercellular communication within tumor microenvironments (TME). These vesicles actively accelerate cancer progression through multiple pathways: driving tumor cell proliferation and metastasis, reprogramming…
-
Journal Article
NFAT3-high dysplastic clones drive IL-17C-mediated local epithelial remodeling and subtype-specific risk stratification in OPMDs
Malignant transformation (MT)-associated risk in oral potentially malignant disorders (OPMDs) involves not only dysplastic epithelial changes but also local remodeling of neighboring epithelium. Nuclear factor of activated T cells 3 (NFAT3) is a stress-responsive transcription factor, yet its role…
-
Journal Article
Extreme procalcitonin elevation without infection in a patient with lung adenocarcinoma undergoing transformation to small-cell lung carcinoma: a case report
Procalcitonin (PCT) is widely used as a biomarker of bacterial infection and sepsis, but its specificity decreases substantially in patients with advanced malignancy.
-
Journal Article
PSMA theranostics in the evolving landscape of metastatic prostate cancer: challenges and opportunities
Metastatic castration-resistant prostate cancer (mCRPC) causes over 375,000 deaths annually. Genomic heterogeneity, androgen receptor (AR) signaling dysregulation, DNA damage repair (DDR) deficiencies, and diverse resistance mechanisms limit conventional therapies, underscoring the need for…
-
Journal Article
Animal models of tongue squamous cell carcinoma: a scoping review of preclinical evidence and clinical relevance
Tongue squamous cell carcinoma (TSCC) presents unique clinical challenges characterized by intricate lingual musculature, early perineural invasion, and a high propensity for occult cervical lymph node metastasis. Despite significant therapeutic advancements, the attrition rate for novel…
-
Journal Article
Mechanism and targeting strategy of the MYBL2-CLSPN-CHK1 axis driving cisplatin resistance in gastric cancer through regulation of DNA damage repair
Cisplatin remains a cornerstone chemotherapeutic agent for advanced gastric cancer; however, the development of drug resistance substantially limits its clinical benefit and is frequently associated with poor prognosis. Recent studies suggest functional interactions between MYBL2, CLSPN and CHK1…
-
Journal Article
Beyond survival: late effects, inflammaging and potential role of flavonoids in long term care of childhood acute lymphoblastic leukemia survivors
Survival outcomes for childhood acute lymphoblastic leukaemia (cALL) in Malaysia have improved markedly, with survival rates of >90 % in the best-risk groups reported recently. However, long-term survivorship remains challenged by a high burden of late effects, with many survivors developing severe…
-
Journal Article
Multi-sequence pituitary tumor MRI–based deep learning model for predicting aggressive acromegaly
Growth hormone-secreting pituitary adenomas (GHPAs) can exhibit highly aggressive oncological behaviors, characterized by local invasion, high recurrence rates, and resistance to standard multimodal therapies including surgery and radiotherapy. While these refractory tumors drive the systemic…
-
Journal Article
Glycolytic/oxidative metabolic reprogramming in lung cancer: clinical implications for precision oncology
Glycolytic or oxidative metabolic reprogramming is increasingly recognized as a central driver of lung cancer progression, aggressiveness, immune evasion, therapeutic resistance, and clinical heterogeneity. Lung tumors exhibit a broad metabolic spectrum ranging from highly glycolytic to oxidative…
-
Journal Article
A comprehensive review of histone deacetylases: implications for pathogenesis and targeted therapy in hepatocellular carcinoma
Histone deacetylases (HDACs) are a family of evolutionarily conserved enzymes that catalyze the removal of acetyl groups from both histone and non-histone proteins, thereby playing a pivotal role in the regulation of gene expression and diverse cellular processes. Growing evidence indicates that…